Search results for merck
Unfortunately, there is a "Jekyll and Hyde" aspect to many pharma companies today as they struggle with the dictates of shareholders and the whole blockbuster model. Nowhere was that more evident
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The drugmaker failed to pay the appropriate rebates to Medicaid and other goverment health care programs, and also paid kickbacks to doctors and hospitals to induce them to prescribe various meds. Th
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Merck & Co., Inc. said that it has reached civil settlements with federal and state authorities to resolve longstanding investigations related to disputes over the proper calculation of Medicaid reba
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
A few day ago, Schering-Plough ceo Fred Hassan appeared on CNBC's Mad Money, where he spoke with Jim Cramer, the hyperactive host, about the controversy surrounding Vytorin. In particular, Cramer as
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Despite a rapidly deteriorating economic situation, total revenues of the Merck Group rose 7.1% to a record € 7,558 million in 2008 due to increased sales of Pharmaceuticals and a 26% increase in roy
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Merck KGaA announced that the European Medicines Agency (EMEA) has recommended to the European Commission the suspension of the marketing authorization for Raptiva® (efalizumab). Raptiva is currently
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) announced that their Boards of Directors have unanimously approved a definitive merger agreement under which Merck and Scheri
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
All in all, the Merck Group performed solidly during the first quarter of 2009. However, Merck is not an island. The recession is affecting the company's results, mainly in the Chemicals business se
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Drug Company Paid Scientific Pulbisher Elsevier To Produce What Was Essentially A Marketing Publication For Vioxx And Fosamax
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
« previous1 next »
